Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Integerbio

Clinical trials sponsored by Integerbio, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug IB-001 enters first human tests for chronic hepatitis b Results expected Apr 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New drug IB-001 enters first human tests for chronic hepatitis b

Disease control Recruiting now

This early-stage study tests a new drug called IB-001 for chronic hepatitis B. It will first check safety in up to 60 healthy volunteers, then test multiple doses in about 30 people with chronic hepatitis B. The main goal is to see if the drug is safe and how the body handles it.

Phase 1 • Sponsor: IntegerBio • Aim: Disease control

Last updated Aug 01, 2026 00:00 UTC